SLC20A2 and Cognitive impairment: All PFBC patients display symmetrical and bilateral calcification of the basal ganglia, but a recent systematic review of the literature indicates that only 60% of the patients carrying SLC20A2 mutations are symptomatic, manifesting both motor and non-motor clinical symptoms, including cognitive deficits, such as memory defects [14–18].